Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
1.36
-0.14 (-9.33%)
At close: May 14, 2025, 2:22 PM
Editas Medicine Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 32.31M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 16.35M | 18.09M | 18.21M | 19.34M | 14.46M | 14.99M | 17.2M | 23.01M | 17.98M | 16.24M | 16.94M | 19.55M | 16.53M | 16.18M | 22.03M | 21.45M | 15.79M | 19.94M | 14.08M | 17.77M | 16.92M | 15.73M | 14.41M | 17.49M | 13.18M | 13.33M | 14.31M | 14.19M | 13.69M | 12.63M | 11.89M | 12.29M | 13.05M | 11.29M | 12.16M | 9.76M | 7.34M | 4.2M | 3.28M | 3.27M |
| Selling, General, and Administrative Revenue Growth | -9.59% | -0.65% | -5.86% | +33.79% | -3.55% | -12.88% | -25.23% | +27.94% | +10.77% | -4.14% | -13.34% | +18.27% | +2.11% | -26.52% | +2.71% | +35.83% | -20.81% | +41.58% | -20.76% | +5.04% | +7.52% | +9.16% | -17.58% | +32.72% | -1.18% | -6.83% | +0.88% | +3.66% | +8.31% | +6.23% | -3.21% | -5.82% | +15.51% | -7.10% | +24.54% | +33.02% | +74.65% | +28.07% | +0.24% | n/a |
| Research and Development Revenue | 47.23M | 47.64M | 52.79M | 47.38M | 68.09M | 5.34M | 29.78M | 37.8M | 52M | 41.33M | 43.66M | 37.98M | 37.55M | 29.27M | 33.75M | 41.94M | 61.51M | 33.92M | 28.01M | 34.57M | 34.79M | 22.7M | 23.57M | 15.84M | 19.2M | 17.44M | 32.72M | 21.3M | 26.42M | 20.4M | 17.32M | 19.02M | 26.84M | 10.83M | 10.43M | 8.88M | 5.83M | 3.85M | 7.28M | 1.89M |
| Research and Development Revenue Growth | -0.86% | -9.76% | +11.42% | -30.42% | +1176.05% | -82.08% | -21.23% | -27.30% | +25.82% | -5.34% | +14.96% | +1.13% | +28.32% | -13.30% | -19.51% | -31.82% | +81.35% | +21.10% | -18.98% | -0.63% | +53.24% | -3.66% | +48.75% | -17.47% | +10.04% | -46.69% | +53.61% | -19.39% | +29.55% | +17.77% | -8.95% | -29.12% | +147.74% | +3.85% | +17.43% | +52.45% | +51.32% | -47.13% | +285.70% | n/a |